- Record: found
- Abstract: not found
- Article: not found
Capmatinib (INC280) is active against models of non-small cell lung cancer and other cancer types with defined mechanisms of MET activation
S Baltschukat, BS Engstler, A Huang, R Kandimalla, H Tomihara, JK Banwait, K Yamamura, G Singh, H Baba, J Kiyokawa, Y KAWAMURA, SM Ghouse, S. Acar, E Barcin, J Martinez-Quintanilla
2019
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.